Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Osteoblastic bone metastases in breast cancer: is not seeing believing?

× No keyword cloud information.

14 in total

1. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.

Authors: F Moog; J Kotzerke; S N Reske
Journal: J Nucl Med Date: 1999-09 Impact factor: 10.057

2. False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases.

Authors: Young-Sil An; Joon-Kee Yoon; Myoung-Hoon Lee; Chul-Woo Joh; Seok-Nam Yoon
Journal: Clin Nucl Med Date: 2005-03 Impact factor: 7.794

3. Whole-body (18)F-FDG PET identifies high-risk myeloma.

Authors: Brian G M Durie; Alan D Waxman; Allesandro D'Agnolo; Cindy M Williams
Journal: J Nucl Med Date: 2002-11 Impact factor: 10.057

4. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.

Authors: Takako Nakai; Chio Okuyama; Takao Kubota; Kei Yamada; Yo Ushijima; Keiko Taniike; Takako Suzuki; Tsunehiko Nishimura
Journal: Eur J Nucl Med Mol Imaging Date: 2005-08-20 Impact factor: 9.236

5. Comparison of FDG-PET and Bone Scans for Detecting Skeletal Metastases in Patients with Non-small Cell Lung Cancer.

Authors:
Journal: Clin Positron Imaging Date: 2000-05

6. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.

Authors: D H Moon; J Maddahi; D H Silverman; J A Glaspy; M E Phelps; C K Hoh
Journal: J Nucl Med Date: 1998-03 Impact factor: 10.057

7. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.

Authors: David E Kang; Richard L White; James H Zuger; Howell C Sasser; Chris M Teigland
Journal: J Urol Date: 2004-05 Impact factor: 7.450

8. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.

Authors: Sendhil Kumar Cheran; James E Herndon; Edward F Patz
Journal: Lung Cancer Date: 2004-06 Impact factor: 5.705

9. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.

Authors: Hans-Jürgen Gallowitsch; Ewald Kresnik; Johann Gasser; Gerhild Kumnig; Isabel Igerc; Peter Mikosch; Peter Lind
Journal: Invest Radiol Date: 2003-05 Impact factor: 6.016

10. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.

Authors: P D Shreve; H B Grossman; M D Gross; R L Wahl
Journal: Radiology Date: 1996-06 Impact factor: 11.105

1 in total

1. Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis.

Authors: Soyeon Park; Joon-Kee Yoon; Su Jin Lee; Seok Yun Kang; Hyunee Yim; Young-Sil An
Journal: Medicine (Baltimore) Date: 2017-12 Impact factor: 1.817

1 in total